Gf Fund Management Co. Ltd. Igm Biosciences, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 716 shares of IGMS stock, worth $837. This represents 0.0% of its overall portfolio holdings.
Number of Shares
716
Previous 716
-0.0%
Holding current value
$837
Previous $4.38 Million
81.19%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IGMS
# of Institutions
82Shares Held
16.2MCall Options Held
26.8KPut Options Held
800-
Baker Bros. Advisors LP New York, NY4.1MShares$4.79 Million0.06% of portfolio
-
Siren, L.L.C. New York, NY3.26MShares$3.81 Million0.21% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.45 Million0.36% of portfolio
-
Black Rock Inc. New York, NY883KShares$1.03 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA876KShares$1.02 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $33.9M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...